Surrey Technology Centre
40 Occam Road
Guildford GU2 7YG
United Kingdom
44 14 8368 5670
https://www.futuramedical.com
Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 12
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. James Henry Barder | CEO & Executive Director | 469.55k | N/A | 1959 |
Ms. Angela Hildreth | COO, Finance Director, Company Secretary & Executive Director | 374.79k | N/A | 1980 |
Mr. Kenneth William James | Head of R&D & Executive Director | 344k | N/A | 1952 |
Dr. William Duncan Potter | Chief Scientific Officer & Adviser to the Board | N/A | 143.75k | 1948 |
Graham Smith | Head of Alliance Partnerships & Supply | N/A | N/A | N/A |
Kevin Langridge | Head of Quality | N/A | N/A | N/A |
Futura Medical plc develops and sells consumer healthcare products for sexual health. Its lead product is Eroxon, a topical gel for the treatment of erectile dysfunction. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
Futura Medical plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.